Equillium inc ofac notified co that after consultation with fda, itolizumab falls within definition of 'cuban-origin pharmaceutical'

Equillium inc - on nov 25, ofac notified co that after consultation with fda, itolizumab falls within definition of 'cuban-origin pharmaceutical'.equillium inc - no further authorization is required from ofac at this time for co's ongoing and planned clinical trials of itolizumab.
EQ Ratings Summary
EQ Quant Ranking